Cell line · CVCL_0042
U2OS
Cancer cell line, Homo sapiens. Osteosarcoma. 443 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. U2OS. Cell lines, record CVCL_0042. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0042
On this page
Cell line
As Cellosaurus gives it.
- Name
- U2OS
- Accession
- CVCL_0042
- RRID
- RRID:CVCL_0042
- Synonyms
- U-2 OS, U-2OS, U-2-OS, U2-OS, U20-S, U20S, 2T
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 15Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone, tibia (in situ)
- Secondary accessions
- CVCL_L856
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers443
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The ROCK1 PHC1 domain mediates recruitment to Rho activity zones and contractility signaling. | Life Sci Alliance | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative proteomics defines FANCA as a multifunctional hub linking DNA repair to translation. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| USP5 acts as a proteolytic switch to control SDE2 function via UBL-directed cleavage. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 443
See all 443 papersRelatives393
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Abcam U2OS ACO1 KO | CVCL_B0YX | Cell lines | |
| Derived from it | Abcam U2OS ATF1 KO | CVCL_E1GJ | Cell lines | |
| Derived from it | Abcam U2OS CD40 KO | CVCL_B0YY | Cell lines | |
| Derived from it | Abcam U2OS COL1A1 KO | CVCL_C0BN | Cell lines | |
| Derived from it | Abcam U2OS DDX1 KO | CVCL_E7RY | Cell lines | |
| Derived from it | Abcam U2OS EZHIP KO | CVCL_C0BP | Cell lines | |
| Derived from it | Abcam U2OS FHL2 KO | CVCL_B0YZ | Cell lines | |
| Derived from it | Abcam U2OS GPR137 KO | CVCL_E1GK | Cell lines | |
| Derived from it | Abcam U2OS HNRNPD KO | CVCL_B0Z0 | Cell lines | |
| Derived from it | Abcam U2OS KDM4C KO | CVCL_C0BQ | Cell lines |
1 to 10 of 393
See all 393 relativesCell banks15
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0042
GET https://conductscience.org/api/cell-lines/v1/CVCL_0042/papers?page=2